When administered together, BPC-157 and TB-500 produce 40-60% greater improvements in healing outcomes compared to either peptide alone, as measured by tensile strength recovery in tendon models, wound closure rates in dermal models, and inflammatory marker reduction in systemic inflammation models
They play a critical role in managing biological functions, including hormone production, immune response, tissue repair, and cell communication
If you are managing conditions like diabetes, proper dosing becomes even more critical
To enhance efficacy and reduce complications, combination therapies employ: MAO-B inhibitors (e.g., rasagiline)
It increases it directly and it tends to suppress something called somatostatin